Nuvation Bio (NUVB) Exchange Rate Effect (2024 - 2026)
Nuvation Bio (NUVB) posted quarterly Exchange Rate Effect of -$172000.0 for Q1 2026, down 213.91% year-over-year from $151000.0 in Q1 2025, and up 23.21% quarter-over-quarter from -$224000.0 in Q4 2025.
Nuvation Bio (NUVB) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Exchange Rate Effect for 3 consecutive years, with -$172000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 213.91% year-over-year to -$172000.0; the TTM figure through Mar 2026 stood at -$588000.0 (down 197.35% YoY), while the FY2025 annual figure was -$265000.0, down 158.5% from the prior year.
- Exchange Rate Effect rose to -$172000.0 in Q1 2026 per NUVB's latest filing, from -$224000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2024 and bottomed at -$742000.0 in Q3 2024.
- Historically, Exchange Rate Effect has averaged $2000.0 across 3 years, with a median of -$96000.0 in 2025.
- On a YoY basis, Exchange Rate Effect climbed as much as 91.37% in 2025 and fell as far as 264.1% in 2025.
- Nuvation Bio's Exchange Rate Effect stood at $1.1 million in 2024, then sank by 120.05% to -$224000.0 in 2025, then increased by 23.21% to -$172000.0 in 2026.
- Business Quant data shows NUVB's Exchange Rate Effect at -$172000.0 in Q1 2026, -$224000.0 in Q4 2025, and -$64000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | -338,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -338,000.00 |
| Jun 30, 2026 | -338,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Dec 31, 2025 | -224,000.00 |
| Dec 31, 2025 | -224,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Dec 31, 2024 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | -742,000.00 |
| Sep 30, 2024 | -742,000.00 |
| Jun 30, 2024 | 78,000.00 |
| Jun 30, 2024 | 78,000.00 |